One Year’s Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

Prior gestational diabetes mellitus (pGDM) is associated with increased risk of nonalcoholic fatty liver disease (NAFLD). Treatment with glucagon-like peptide 1 (GLP-1) receptor agonists has shown beneficial effects in NAFLD patients. We evaluated the effect of the GLP-1 analogue liraglutide on NAFL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Vedtofte, Louise, Bahne, Emilie, Foghsgaard, Signe, Bagger, Jonatan I., Andreasen, Camilla, Strandberg, Charlotte, Gørtz, Peter M., Holst, Jens J., Grønbæk, Henning, Svare, Jens A., Clausen, Tine D., Mathiesen, Elisabeth R., Damm, Peter, Gluud, Lise L., Knop, Filip K., Vilsbøll, Tina
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7601647/
https://ncbi.nlm.nih.gov/pubmed/33036179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9103213
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados